Mourad M, Atallah E P, Raad G, Haddad R, Richa S
Department of Psychiatry, University Hospital Center, Hôtel-Dieu de France, Saint Joseph University of Beirut, Beirut, Lebanon; Department of Psychiatry, Faculty of Medicine, Saint Joseph University of Beirut, Beirut, Lebanon.
Department of Psychiatry, University Hospital Center, Hôtel-Dieu de France, Saint Joseph University of Beirut, Beirut, Lebanon; Department of Psychiatry, Faculty of Medicine, Saint Joseph University of Beirut, Beirut, Lebanon.
Encephale. 2024 Feb;50(1):40-47. doi: 10.1016/j.encep.2022.11.006. Epub 2023 Jan 28.
This study aims to identify the prevalence of Ultra High Risk (UHR) adults in a sample of patients in Lebanon and to compare screening and diagnostic tools.
This is a cross-sectional pilot study which targeted patients aged 17-30 years willingly seeking psychiatric care in a university hospital in Beirut, Lebanon. Participants were invited to fill either the English or the French version of the Prodromal Questionnaire (respectively, PQ16 or fPQ16). The abbreviated version of the "Comprehensive Assessment of At-Risk Mental States" (CAARMS) was then administered to all participants. The latter were subsequently sorted into one of the three UHR groups - vulnerability group, attenuated psychosis (APS), intermittent psychosis (BLIPS) - or were diagnosed as suffering from a psychotic disorder.
Thirty-one patients participated in this study. The prevalence of positive screening on the PQ16/fPQ16 and positive diagnosis of UHR on the CAARMS were respectively of 61.29% and 45%. The APS group was the most prevalent (71.42%). A positive psychosis screening on PQ16/fPQ16 was statistically related to a UHR diagnosis on CAARMS (p-value: 0.011 on Chi test), OR=8.5 (95% CI: 1.4-50.9; p-value: 0.018). No relation was found between PQ16/fPQ16 results and risk stratification or between the number of "True" responses on PQ16/fPQ16 and the intensity of symptoms on CAARMS. PQ16/fPQ16 statements 5, 9, 11 and 16 predicted a UHR diagnosis on CAARMS (p-value of 0.045, 0.006, 0.045 and 0.045, respectively).
This two-stage strategy for identifying UHR patients can be adopted in a tertiary health care center.
本研究旨在确定黎巴嫩患者样本中超高风险(UHR)成年人的患病率,并比较筛查和诊断工具。
这是一项横断面试点研究,目标是黎巴嫩贝鲁特一家大学医院中自愿寻求精神科护理的17至30岁患者。邀请参与者填写英文版或法文版的前驱症状问卷(分别为PQ16或fPQ16)。然后对所有参与者进行“高危精神状态综合评估”(CAARMS)的简化版评估。随后,将后者分为三个UHR组之一——易损组、精神病性症状衰减综合征(APS)、间歇性精神病性症状(BLIPS)——或被诊断为患有精神障碍。
31名患者参与了本研究。PQ16/fPQ16筛查阳性率和CAARMS上UHR的阳性诊断率分别为61.29%和45%。APS组最为常见(71.42%)。PQ16/fPQ16上的精神病筛查阳性与CAARMS上的UHR诊断在统计学上相关(卡方检验p值:0.011),OR=8.5(95%CI:1.4 - 50.9;p值:0.018)。未发现PQ16/fPQ16结果与风险分层之间的关系,也未发现PQ16/fPQ16上“是”的回答数量与CAARMS上症状强度之间的关系。PQ16/fPQ16的第5、9、11和16条陈述预测了CAARMS上的UHR诊断(p值分别为0.045、0.006、0.045和0.045)。
这种识别UHR患者的两阶段策略可在三级医疗保健中心采用。